Vimarsana
Biggest News Aggregation in the World

Page 25 - Diagnostics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Inc Today - Breaking & Trending Today

CYduct Diagnostics Inc. Advocates for Breast Cancer Awareness Month: ... - Vimarsana News

CYduct Diagnostics Inc. Advocates for Breast Cancer Awareness Month: ...

CYduct Diagnostics Inc. Advocates for Breast Cancer Awareness Month: ...

Global Emerging Infectious Disease Diagnostics Market - Vimarsana News

Global Emerging Infectious Disease Diagnostics Market

Dublin, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The

Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa - Vimarsana News

Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

Unraveling Quest Diagnostics Inc's Dividend Performance: A Comprehensive Analysis - Vimarsana News

Unraveling Quest Diagnostics Inc's Dividend Performance: A Comprehensive Analysis

Quest Diagnostics Inc(NYSE:DGX) recently announced a dividend of $0.71 per share, payable on 2023-10-23, with the ex-dividend date set for 2023-10-05. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's deep dive into Quest Diagnostics Incs dividend performance and assess its sustainability.

Source: yahoo.com
KDx Diagnostics Inc. announces issuance of patents covering URO17® NON-INVASIVE Urine Test for Bladder Cancer in the United States and Europe - Vimarsana News

KDx Diagnostics Inc. announces issuance of patents covering URO17® NON-INVASIVE Urine Test for Bladder Cancer in the United States and Europe

/PRNewswire/ -- KDx Diagnostics Inc., a leading innovator in non-invasive bladder cancer tests, is pleased to announce the issuance of important patents in the...